Article
Multiple features of cell-free mtDNA for predicting transarterial chemoembolization response in hepatocellular carcinoma
26 Feb 2025
Abstract excerpt
BACKGROUND: Transarterial chemoembolization (TACE) is the primary treatment modality for advanced HCC, yet its efficacy assessment and prognosis prediction largely depend on imaging and serological markers that possess inherent limitations in terms of real-time capability, sensitivity, and specificity. Here, we explored whether multiple features of cell-free mitochondrial DNA (cf-mtDNA), including copy number,...
Topics
Join the communities discussing this publication.